AM, T. (2000). Thioridazine: Re-evaluating the risk/benefit equation. Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 12(3), 147. https://doi.org/10.1023/a:1009064901907
Chicago Style (17th ed.) CitationAM, Timell. "Thioridazine: Re-evaluating the Risk/benefit Equation." Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists 12, no. 3 (2000): 147. https://doi.org/10.1023/a:1009064901907.
MLA (9th ed.) CitationAM, Timell. "Thioridazine: Re-evaluating the Risk/benefit Equation." Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists, vol. 12, no. 3, 2000, p. 147, https://doi.org/10.1023/a:1009064901907.
Warning: These citations may not always be 100% accurate.
